Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 23,266 | 17,618 | 15,873 | 11,650 | 11,152 |
| Operating Income | -23,266 | -17,618 | -15,873 | -11,650 | -11,152 |
| Other Income | 44 | 67 | 122 | 229 | 426 |
| Pre-tax Income | -23,222 | -17,551 | -15,751 | -11,421 | -10,726 |
| Net Income Continuous | -23,222 | -17,551 | -15,751 | -11,421 | -10,726 |
| Net Income | $-23,222 | $-17,551 | $-15,751 | $-11,421 | $-10,726 |
| EPS Basic Total Ops | -0.34 | -0.25 | -0.22 | -0.17 | -0.16 |
| EPS Basic Continuous Ops | -0.34 | -0.25 | -0.23 | -0.17 | -0.16 |
| EPS Diluted Total Ops | -0.34 | -0.25 | -0.22 | -0.17 | -0.16 |
| EPS Diluted Continuous Ops | -0.34 | -0.25 | -0.23 | -0.17 | -0.16 |
| EBITDA(a) | $-22,861 | $-17,258 | $-15,813 | $-11,185 | $-11,097 |